PHILADELPHIA--(BUSINESS WIRE)--TTC, llc and the University of the Sciences in Philadelphia (USciences) announce highly renowned leaders in the Pharmaceutical and CRO industries to speak at the “The 2nd Annual State of Clinical Development Cost” conference. This 2-day event will feature key speakers such as John Hubbard, Ph.D., F.C.P., Senior Vice President and Worldwide Head, Development Operations at Pfizer and Peter Aurup, MD., Vice President, Head Global Clinical Trial Operations at Merck. Dr. Hubbard will bring to light the current industry practices in the pharmaceutical industry while Dr. Aurup will be discussing the future challenges pharmaceutical companies will be facing.
